STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Not yet recruiting
- Depression
- +2 more
- Iterative exposure to suxamethonium during ECT sessions
- (no location specified)
2022-01-14
Jan 14, 2022B
Recruiting
- Personal Protective Equipment
- Transparent, reusable respirator
- Boston, Massachusetts
- +2 more
2021-08-02
Aug 2, 2021G
Completed
- Sunscreening Agents
- Physiogel Daily Defence Protective Day Cream Light
- ISO 24444:2010 P3 Standard Sunscreen
- Schenefeld, Schleswig-Holstein, GermanyGSK Investigational Site
2019-01-15
Jan 15, 2019A
Completed
- Anesthesia
- +2 more
- maintenance with sevoflurane
- maintenance with propofol
- Athens, GreeceAretaieion University Hospital
2022-01-30
Jan 30, 2022B
Completed
- Neuromuscular Blockade
- +2 more
- Neuromuscular blocking agents
- Boston, Massachusetts
- +1 more
2021-08-19
Aug 19, 2021M
Completed
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Ivermectin / Iota-Carrageenan
- Tucumán, ArgentinaSI.PRO.SA, Ministerio de Salud Pública
2021-02-22
Feb 22, 2021O
ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED) - 2005
Completed
- High Blood Pressure
- losartan potassium
- Comparator: Placebo
- (no location specified)
2022-02-04
Feb 4, 2022U
Recruiting
- Parkinson Disease
- Citalopram 20mg
- Placebo
- Ann Arbor, MichiganUniversity of Michigan
2022-03-30
Mar 30, 2022M
Completed
- Preterm Infant
- +2 more
- Oropharyngeal Administration of Mother's Milk (OPAMM)
- Mansourah, El Dakahlya, EgyptMansoura University Children Hospital
2020-06-15
Jun 15, 2020S
Completed
- Influenza
- FluMist®
- (no location specified)
2021-09-21
Sep 21, 2021A
Active, not recruiting
- COVID-19
- Paris, FranceHEGP
2021-10-01
Oct 1, 2021E
Completed
- COVID-19
- Licorice extract
- Assiut, EgyptFaculty of Medicine, Assiut University
2022-03-21
Mar 21, 2022U
Recruiting
- Respiratory Distress Syndrome, Adult
- Hypothermia
- +2 more
- Newark, Delaware
- +13 more
2021-12-28
Dec 28, 2021N
Completed
- Autoimmune/Connective Tissue Diseases
- +3 more
- Bethesda, MarylandNational Institute of Environmental Health Sciences (NIEHS), 900
2022-04-07
Apr 7, 2022Q
R
Completed
- HIV
- Game Changers
- Kampala, UgandaInfectious Diseases Institute
2020-05-27
May 27, 2020U
Not yet recruiting
- Mucositis (MeSH Unique ID: D052016)
- Stomatitis (MeSH Unique ID: D013280)
- 1. alpha acid lipoic - tables
- +3 more
- (no location specified)
2022-01-26
Jan 26, 2022H
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVID-19
- Tenofovir/ Emtricitabine ( 300 mg / 200 mg daily during 60 days) + Personal Protective Equipment (PPE)
- Placebo (1 tablet daily during 60 days) + Personal Protective Equipment (PPE)
- (no location specified)
2020-08-18
Aug 18, 2020N
Recruiting
- Skin Condition
- Rice ceramide supplementation
- Cheras, Kuala Lumpur, Malaysia
- +1 more
2022-04-05
Apr 5, 2022M
Recruiting
- Postoperative Pulmonary Complications
- Preoperative Education
- +4 more
- San Francisco, California
- +11 more
2021-02-16
Feb 16, 2021U
Recruiting
- Covid19
- SARS-CoV Infection
- Johannesburg, Gauteng, South Africa
- +1 more
2021-09-28
Sep 28, 2021T
Completed
- Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents
- TAK-935
- [18F]MNI-792 (tracer)
- New Haven, Connecticut(unnamed)
2017-02-28
Feb 28, 2017V
Recruiting
- Hepatitis B
- VVX001
- Placebo
- Graz, Austria
- +1 more
2021-04-02
Apr 2, 2021N
Completed
- Malaria
- PfSPZ Vaccine
- +5 more
- Bamako, MaliUniversity of Bamako (USTTB/MRTC)
2021-04-19
Apr 19, 2021Y
Completed
- Gastric Adenoma
- Early Gastric Cancer
- Seoul, Korea, Republic ofSevrance hospital
2019-03-25
Mar 25, 2019